Pharmaceutical News

RSS

Older adults with recent heart attack, kidney dysfunction lack long-term medication adherence: Study

Among older adults with a recent heart attack, those with lower levels of kidney function are less likely to take their medications as prescribed, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology.

14 Jan 2011

IDRI receives Bill and Melinda Gates Foundation multi-million dollar grant to identify new leads in TB

The Infectious Disease Research Institute today announced it has received a multi-million dollar grant from the Bill and Melinda Gates Foundation for "Chemical genomics for the identification of targets and leads in tuberculosis."

14 Jan 2011

ITM scientists to combat tapeworm infection using drugs

The Institute of Tropical Medicine Antwerp increases its fight in Congo against the pork tapeworm, in spite of its name also a human parasite, causing epilepsy.

14 Jan 2011

FDA approves Cumberland's Acetadote Injection

Cumberland Pharmaceuticals today announced that it has received approval from the U.S. Food and Drug Administration for a new formulation of Acetadote Injection, the Company's product used to treat acetaminophen poisoning.

13 Jan 2011

FDA calls for cuts in Acetaminophen in painkillers

The US FDA has asked for a limit on the amount of acetaminophen in prescription pain medicines in an effort to reduce the risk of liver damage. The announcement yesterday asked manufacturers to limit combination drugs such as the opioids Percocet and Vicodin to 325 milligrams of acetaminophen per pill and asked them to carry a “black box” warning about potential liver failure. At present these combinations carry up to 750 milligrams of acetaminophen.

13 Jan 2011

Abuse of legal substances

The Internet, smart phones and teens' endless search for self-acceptance in their technology connected yet isolated world is driving a revival of substance abuse of salvia, an herb from flower seeds that induces psychedelic effects but is not detectable with usual drug tests, and synthetic cannabis, a psychoactive herbal and chemical concoction, also undetectable, popularly known around high schools as "spice".

13 Jan 2011

PPPI-III conference to focus on fundamental research and industrial application of particulate processing

Over 80% of all pharmaceutical products are in the solid dosage form. Particulate processes therefore abound in the pharmaceutical industry. These include crystallization; drying, granulation, and coating; tablet compaction; fine powder transport, mixing, and blending. These and other particulate processes are used for the large-scale manufacture of tablets and capsules as well as dry powder inhalants for public consumption.

13 Jan 2011

Study supports use of PRX as an anti-cataract agent

Scientists are reporting a scientific basis for the long-standing belief that a widely used non-prescription drug in China and certain other countries can prevent and treat cataracts, a clouding of the lens of the eye that is a leading cause of vision loss worldwide. Their study appears in Inorganic Chemistry, an ACS journal.

13 Jan 2011

BP-lowering medications provide long-term benefit of reducing death risk from cardiovascular disease

In a study published in December 2010, in Hypertension, a journal of the American Heart Association, investigators have shown that early treatment with blood pressure-lowering medications provides a long-term benefit of reducing the risk of death from cardiovascular disease.

13 Jan 2011

Antibiotic treatment may be sufficient to overcome River Blindness

The team found that a bacterium inside the worm acts as a 'disguise' for the parasite, resulting in the immune system reacting to it in an ineffective way. The bacteria protect the worm from the body's natural defences, but once the bacteria are removed with antibiotics, the immune system responds appropriately, releasing cells, called eosinophils, that kill the worm.

13 Jan 2011

Genomic research could help doctors better target oxaliplatin drug to treat colorectal cancer patients: Study

Genomic research could help doctors better target a drug widely used to treat colorectal cancer patients, according to a study by Genomic Health Inc. and the Translational Genomics Research Institute.

13 Jan 2011

Pfizer initiates rolling submission of crizotinib NDA for ALK-positive advanced NSCLC

Pfizer Inc. announced today that it has initiated the rolling submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for crizotinib (PF-02341066), an oral first-in-class anaplastic lymphoma kinase (ALK) inhibitor for the treatment of patients with advanced non-small cell lung cancer (NSCLC) whose tumors are ALK-positive. Pfizer expects to complete the submission in the first half of 2011.

13 Jan 2011

FDA accepts to review Fibrocell Science's azficel-T drug

Fibrocell Science, a biotechnology company focused on the development of autologous cell therapies for aesthetic, medical and scientific applications, announced today that the U.S. Food & Drug Administration has accepted for review the Company's complete response submission for azficel-T, proposed brand name laViv, for the treatment of moderate to severe nasolabial folds and wrinkles.

12 Jan 2011

K-V Pharmaceutical provides update on FDA review of NDA for Gestiva

K-V Pharmaceutical Company today issued an update on the status of the U.S. Food and Drug Administration's review of Hologic, Inc.'s New Drug Application for Gestiva as a treatment for the prevention of preterm birth in women with a singleton pregnancy who have a history of singleton spontaneous preterm birth.

12 Jan 2011

FDA panel rejects new pancreatic enzyme replacement drug

Eli Lilly & Co did not win the support of the U.S. advisory panel on Wednesday for its one-of-its kind drug not made from pig enzymes to help certain pancreatic patients digest food. A Food and Drug Administration panel of outside experts in a 7-4 vote said they were not convinced the experimental medicine, known chemically as liprotamase, worked well enough for patients to absorb enough needed nutrients. One member of the panel abstained.

12 Jan 2011

US most susceptible to brand erosion post patent expiry

On average, small molecule brands in the US experienced the greatest degree of brand erosion following patent expiry and exposure to direct generic competition, according to a new report from independent market analyst, Datamonitor.

12 Jan 2011

Study highlights importance of independent evaluation of Tamiflu drug

Tom Jefferson and colleagues from the Cochrane Group argue that the current system for assessing the safety and effectiveness of drugs, based on published trial data only, is "wholly inadequate" and "ethically dubious."

12 Jan 2011

Study shows delivering cancer drug in hydrophobic nanoparticle is a safe and effective prostate cancer therapy

Researchers at MIT and Brigham and Women's Hospital have shown that they can deliver the cancer drug cisplatin much more effectively and safely in a form that has been encapsulated in a nanoparticle targeted to prostate tumor cells and is activated once it reaches its target.

12 Jan 2011

New research identifies nutrition inadequacy among Americans

At a time when the country is facing an obesity epidemic, the problem of nutrition inadequacy is often overlooked. Yet, many Americans are overweight and undernourished, concludes a new study called "What America's Missing."

12 Jan 2011

Study: 23% of doctors have negative perceptions on quality, effectiveness of generic drugs

A new study by researchers at Harvard, Brigham and Women's Hospital and CVS Caremark finds that 23 percent of doctors' have negative perceptions of the effectiveness and quality of generic drugs and that may lead to doctors prescribing unnecessarily expensive medications.

12 Jan 2011

Pharmaceutical News

Older adults with recent heart attack, kidney dysfunction lack long-term medication adherence: Study

IDRI receives Bill and Melinda Gates Foundation multi-million dollar grant to identify new leads in TB

ITM scientists to combat tapeworm infection using drugs

FDA approves Cumberland's Acetadote Injection

FDA calls for cuts in Acetaminophen in painkillers

Abuse of legal substances

PPPI-III conference to focus on fundamental research and industrial application of particulate processing

Study supports use of PRX as an anti-cataract agent

BP-lowering medications provide long-term benefit of reducing death risk from cardiovascular disease

Antibiotic treatment may be sufficient to overcome River Blindness

Genomic research could help doctors better target oxaliplatin drug to treat colorectal cancer patients: Study

Pfizer initiates rolling submission of crizotinib NDA for ALK-positive advanced NSCLC

FDA accepts to review Fibrocell Science's azficel-T drug

K-V Pharmaceutical provides update on FDA review of NDA for Gestiva

FDA panel rejects new pancreatic enzyme replacement drug

US most susceptible to brand erosion post patent expiry

Study highlights importance of independent evaluation of Tamiflu drug

Study shows delivering cancer drug in hydrophobic nanoparticle is a safe and effective prostate cancer therapy

New research identifies nutrition inadequacy among Americans

Study: 23% of doctors have negative perceptions on quality, effectiveness of generic drugs

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News